Dr. Elsayed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7 Wilson CV
Hillsborough, NJ 08844Phone+1 908-874-3982
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Nassau University Medical CenterResidency, Internal Medicine, 1996 - 1999
University of Gezira Faculty of MedicineClass of 1990
Certifications & Licensure
NJ State Medical License 2002 - 2025
DC State Medical License 1999 - 2020
VA State Medical License 1999 - 2006
Publications & Presentations
PubMed
- 43 citationsPhase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndrome.F. Child, Pablo L. Ortiz-Romero, Rute Alvarez, Martine Bagot, Rudolf Stadler
The British Journal of Dermatology. 2016-07-01 - 292 citationsPhase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancerKenneth J. Pienta, Jean-Pascal Machiels, D. Schrijvers, Boris Alekseev, Mikhail Shkolnik
Investigational New Drugs. 2013-06-01 - 75 citationsTeclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma.Kodandaram Pillarisetti, Gordon Powers, Leopoldo Luistro, Alexander Babich, Baldwin Eric Thomas
Blood Advances. 2020-09-22
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
